España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
DEA
Trump Administration Could Ban Amazon's Top-Selling Routers Linked To Chinese Cyberattacks: Report
DEA's Cannabis Rescheduling Hearing Set To Begin In January 2025 As Controversy Mounts
Trump's DEA Drama: He Didn't Quit, I Fired Him — A Tale Of Pastors, Pandemic And Hurt Feelings
DEA's Cannabis Rescheduling Hearing Set To Begin In January 2025 As Controversy Mounts
Trump's DEA Drama: He Didn't Quit, I Fired Him — A Tale Of Pastors, Pandemic And Hurt Feelings
$13-Billion Drug War Funded By U.S. Taxpayers Fuels Violence In Developing Countries: New Report
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
$13-Billion Drug War Funded By U.S. Taxpayers Fuels Violence In Developing Countries: New Report
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
Trump's DEA Pick Withdraws From Consideration, Will Keep Job As Florida Sheriff
Nebraska's Two-Front War On Cannabis
Read More...
DEA Recent News
DEA LIVE Hearings On Marijuana Rescheduling, What To Expect
DEA's marijuana rescheduling hearings could reshape cannabis policy, easing research and tax rules while stopping short of full legalization.
Trump's Kash Patel FBI Pick And DEA Nominee Could Signal Shift In Drug Enforcement Priorities
Patel's vision for the FBI involves a sweeping restructuring, which includes dismantling its intelligence-gathering functions and purging its ranks of employees who are viewed as disloyal to Trump.
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.
Elon Musk, Vivek Ramaswamy: Here's An Agency You Might Want To Cut Back On And Save $40 Billion A Year
With Donald Trump's new DOGE initiative, it may be time to dismantle the DEA and legalize cannabis.
Prohibitionist Group Denies Collusion Allegations Ahead Of DEA Cannabis Rescheduling Hearing
SAM denies collusion with the DEA amid cannabis rescheduling hearing allegations, calling the claims baseless distractions from the issue's merits.
DEA Denies Allegations Of Colluding With Anti-Marijuana Group While Involved In Cannabis Rescheduling Process
DEA denies allegations of improper talks with an anti-marijuana group during rescheduling, treats claims as "gossip" and requesting dismissal
DEA Judge Blocks Researcher's Motion In Cannabis Rescheduling Case
DEA denies MedPharm's motion to join marijuana rescheduling hearing, raising concerns over exclusion and bias favoring prohibitionists.
DEA Banned From Random Airport Searches After Scathing Justice Department Report Uncovers Corruption
The DEA has been barred from conducting random searches of travelers' belongings at airports and transit hubs following a Justice Department investigation that exposed corrupt practices.
US Overdose Deaths Decline As Fentanyl Potency Weakens, Harm Reduction Expands
U.S. overdose deaths decline 14.5% in 2024, driven by weaker fentanyl potency, harm reduction efforts, and shifts in drug use behavior.
DEA Is Compromised, DOJ Should Replace It In Cannabis Rescheduling, Claims Joint Motion
Veterans Group Challenges DEA For Seat At Cannabis Debate Table
Texas Smoke Shop Owners Sue DEA Over 'Intimidation And Bullying' Tactics In Raid Of Legal Retail Store
Texas smoke shop owners are suing law enforcement after August raids, alleging rights violations and unlawful seizures.
House Democrats Urge DEA To Speed Up Cannabis Rescheduling
House Democrats urge the DEA to reschedule cannabis under federal law while hinting at possible future descheduling.
Meet The Man Serving A 40-Year Sentence For Non-Violent Cannabis Charges, Awaiting Pardon From Biden
Edwin Rubis, now 56, was 29 when the DEA arrested him and charged him. No drugs, guns or money were found in his possession.
Cannabis Experts Say Weed Reform Is A Race Against Time, Is The DEA Delaying Biden's Rescheduling Proposal?
While rescheduling could provide some immediate relief, particularly by eliminating the 280E tax burden, the path forward remains uncertain.
EXCLUSIVE: DEA Stalling Hinders Critical Clinical Trials For Debilitating Conditions, Says MMJ BioPharma CEO
MMJ BioPharma's lawsuit against the DEA delays vital cannabis research for MS and HD treatments. Could this legal battle reshape policy?
Will The DEA Complete Cannabis Rescheduling? Hear From Experts The Day After Harris-Trump Debate
If cannabis is reclassified, the industry could see tax reforms, research opportunities, and the development of new regulatory frameworks.
U.S. Court Says This Cannabinoid Is Legal, Rejects DEA's Position On Controlled Substances
A U.S. appeals court rules that THC-O is a legal cannabinoid, rejecting the DEA's stance and expanding legal area for hemp-derived products.
Cannabis Research Program At Ole Miss Approved, Funded By Mississippi Legislature
Mississippi Legislature funds new Medical Cannabis Research Program at Ole Miss, advancing studies on therapeutic benefits of cannabis.
Cannabis Rescheduling Could Reverse 'Decades Of Misguided Drug Policy,' Says Key Industry Organization Following DEA Hearing Rescheduling (UPDATED)
The rescheduling of cannabis has been a long-standing issue within the industry; it currently sits alongside substances like heroin.
DEA Warns Of Crackdown On Ketamine Prescribing Following Matthew Perry's Death
DEA warns of crackdown on ketamine prescribing after Matthew Perry's death, likening it to opioid crisis. What about needed ketamine therapy?
DEA Can Still Make Cannabis Arrests In Legal Weed States Like Ohio, But It's Not 'Our Goal'
A DEA official told an Ohio radio network that its primary focus is on arresting major drug traffickers, not weed users.
DEA Faces Legal Challenge Over Denial Of Psilocybin For End-Of-Life Care
A federal appeals court hears a critical case on whether the DEA must allow psilocybin use for terminally ill patients under Right to Try laws